The Zika virus strain linked to surging cases of neurological disorders and birth defects in Latin America has now been found in Africa, health officials said Friday, as the first fatality on French territory was reported ...
May 20, 2016
0
32
The World Health Organization will hold an emergency meeting Thursday on the yellow fever outbreak that has hit hardest in Angola but risks spreading further if vaccinations are not ramped up.
May 17, 2016
0
4
(HealthDay)—The list of neurological disorders potentially associated with the Zika virus continues to grow, according to a letter to the editor and a perspective piece published online March 9 in the New England Journal ...
Mar 10, 2016
0
1
Using a drug compound created to treat cancer, University of California, Irvine neurobiologists have disarmed the brain's response to the distinctive beta-amyloid plaques that are the hallmark of Alzheimer's disease.
Feb 29, 2016
0
318
(HealthDay)—Many Ebola survivors have brain symptoms that last long after other signs of the potentially fatal infection are gone, a new study finds.
Feb 25, 2016
0
40
The World Health Organization on Wednesday released its initial response plan to the Zika virus outbreak, launching a funding appeal for the $56 million (50 million euros) operation.
Feb 17, 2016
0
13
Federal and international health officials confessed Tuesday to an encyclopedic list of unanswered questions about the fast-spreading Zika virus, which in a matter of months has become an international public health crisis.
Feb 17, 2016
0
4
A growing body of scientific evidence indicates that uncontrolled high blood pressure is not only the leading cause of stroke but may also be linked to cognitive decline and dementia. Today, the National Institutes of Health's ...
Feb 3, 2016
0
12
Graph theoretical analysis is proving to be helpful in understanding complex networks in the brain. Investigators in the Republic of Korea used a graph theoretical approach in examining the changes in the configuration of ...
Jan 14, 2016
0
1
An experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with support from the NIH Blueprint Neurotherapeutics Network, ...
Jan 1, 2016
1
295
